H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Michael Seiler, Akihide Yoshimi(Memorial Sloan Kettering Cancer Center), Rachel Darman, Betty Chan, Gregg F. Keaney, Michaël Thomas, Anant A. Agrawal, Benjamin Caleb, Alfredo Csibi, E. Egan Sean(Eisai (United States)), Peter Fekkes, Craig Karr, Virginia M. Klimek(Memorial Sloan Kettering Cancer Center), George Lai(Eisai (United States)), Linda Lee, Pavan Kumar, Stanley Chun-Wei Lee(Memorial Sloan Kettering Cancer Center), Xiang Liu, Crystal MacKenzie, Carol Meeske, Yoshiharu Mizui, Eric Padron(Moffitt Cancer Center), Eunice Park, Ermira Pazolli, Shouyong Peng, Sudeep Prajapati, Justin Taylor(Memorial Sloan Kettering Cancer Center), Teng Teng, John Wang, Markus Warmuth, Huilan Yao, Lihua Yu, Ping Zhu, Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Peter G. Smith, Silvia Buonamici
Nature Medicine
February 19, 2018
Cited by 506Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis